Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies.
Dr Peter Groves
Dr Peter Groves is a Consultant Interventional Cardiologist based at the University Hospital of Wales, Cardiff since 1996. He served as Clinical Director of Cardiothoracic Services from 2002 to 2009. Dr Groves undertakes percutaneous cardiac procedures for structural and coronary heart disease and leads the Structural Heart Disease Interventional Programme in South-East Wales.
Dr Groves qualified from the University of Newcastle-Upon-Tyne Medical School in 1984 MBBS (Hons). He completed General Medical training in the Newcastle University Hospitals culminating in MRCP and began his specialist Cardiology training in Cardiff in 1988. He undertook Cardiovascular scientific and clinical research in Cardiff (BHF Fellowship; MD awarded by the University of Newcastle-Upon-Tyne in 1993) and at the University of Freiburg (Alexander von Humboldt Scholar). Dr Groves was Senior Registrar in Cardiology at the Royal Brompton and National Heart Hospital, London 1994-1996.
Dr Groves is past-President of the Welsh Cardiovascular Society and previous Council member of the British Cardiovascular Society. He represents the Welsh Government as the chairman of the MHRA Devices Expert Advisory Committee (DEAC) and has worked with NICE since 2006. He served as a Committee member on the Interventional Procedures Advisory Committee (2006-2009) and then joined the Medical Technologies Advisory Committee in 2009, serving as the inaugural Vice-Chairman of the Committee from 2009-2015.
Dr Groves was appointed as Chair of the Medical Technologies Advisory Committee in 2016.
Professor Fiona Denison
Fiona Denison is a Professor of Translational Obstetrics at the University Edinburgh of MRC. She holds a clinical academic and obstetric lead for maternal obesity. She has a specific interest in the design and development of innovative new technologies for clinical care across a range of specialties including obstetrics, midwifery and anaesthetics.
Ms Sue Bennett
Sue Bennett, MPhil, took early retirement in 1994 after developing spinal problems. She is a member of the DH HCAI Service Users in Research Forum. Sue was a Trustee of the Bladder and Bowel Foundation (formerly Incontact) for 8 years and still represents the B&BF at The Urology User Groups Coalition. She is also a member of Disability Rights UK and Spinal Injuries Association.
Sue has previously been a member of the NHS Information Authority Public Reference Group, was a member of the NICE Faecal Incontinence Guideline Development Group, and on the NICE/NPSA pilot Patient Safety Advisory Committee. She has been a lay member of NICE Interventional Procedures Advisory Committee since 2007. Her main interests include disability equality especially in relation to health issues.
Dr Mike Burrows
Mike Burrows is the National AHSN Network Coordination Director. Until recently he was the Managing Director of the Greater Manchester Academic Health Science Network (AHSN). Previously he was the Director of the NHS England (Greater Manchester) Area Team, a role that followed on from that of Chief Executive of NHS Greater Manchester. From May 2004 until May 2011 he was Chief Executive of Salford Teaching Primary Care Trust.
Originally a Doctor of Biochemistry, Mike has worked in the NHS for 31 years now, both in the finance discipline and general management. He has an active interest in the use of evidence based medicine and a passionate believer in the benefits of strong ties between the NHS and academia. In this respect he was one of the founding board members of the Manchester Academic Health Sciences Centre (MAHSC) and under his leadership developed Salford PCT to be one of the leading research active PCTs in the country.
In his current role, Mike has the responsibility for engaging the NHS, academia and industry to generate health and wealth, particularly through the adoption and diffusion of innovation and research output.
In his previous role as the Chief Executive of NHS Greater Manchester Mike shaped the concept of a major programme of service transformation in Greater Manchester entitled ‘Healthier Together’ which is now being led and delivered by the 12 CCGs.
Mike is the Deputy Chairman of the University of Salford.
Professor Daniel Clark
Professor Daniel Clark is Head of Clinical Engineering at Nottingham University Hospital NHS Trust. The Clinical Engineering service in Nottingham is one of the largest in Europe and provides the full scope of equipment services including: device evaluation, commissioning, service and maintenance, decommissioning and disposal. This service has specialist teams in renal technical support, non-ionising radiation, anaesthetics and ventilators and general medical and also provides a comprehensive equipment library service and a medical devices training unit.
Daniel also leads an innovation and research unit that designs and produces novel medical devices plus a device evaluation and compliance team. He has considerable experience of evaluating new technologies and introducing them into the healthcare setting. He is a device specialist in optics, optoelectronics and optical imaging systems and holds a number of grants for device development and evaluation. He Chairs the Trust's Medical Devices Group and sits on a number of trust-wide risk committees.
Mr Steve Fearn
Steven Fearn is Health Economics and Reimbursement Manager for Abbott in the UK. He graduated in Chemistry from the University of Leeds and later completed a PhD in Biological Sciences at the University of Sheffield. His work within industry has focussed on developing clinical and cost effectiveness evidence to help support the uptake of medical technology, primarily in the fields of coronary artery disease, heart failure and peripheral vascular disease.
Steve has participated in many NICE evaluations from the industry perspective and has previously held a seat on one of NICE’s Topic Selection Consideration panels.
Dr Teik Goh
Teik Goh is currently a GP Partner at The Garth Surgery in Guisborough a market town on the edge of North Yorkshire. Until recently, he worked as GP with special interest in older people in County Durham, and was the inaugural Medical Director then CEO/MD of ELM Alliance Ltd, the South Tees GP Federation of 43 general practices.
In his previous roles, Teik led the setting up of research network of 15 practices, extended hours and out-of-hour service as well as an innovative care home enhanced support service. In his current roles, Teik is the GP lead for the community prehabilitation project – one stop preoperative programme to improve patient fitness prior to surgery.
Teik completed MSc in Health Management at Imperial College London Business School, did health economics research at the University of Aberdeen and health services research at Newcastle University, before completing his GP training in the North East. He maintains interest in primary care research and implementation in general practice.
Professor Shaheen Hamdy
Professor Shaheen Hamdy is currently a Professor in Medicine (Neurogastroenterology) within the University of Manchester, Centre Lead for GI Sciences, Institute of Inflammation and Repair and Director of the Neuroscience Research Institute. He holds a clinical academic contract, delivering clinical care at Salford Royal Hospital NHS Trust for 50% of his contracted time. He is also lead academic clinician for the NIHR academic training programme in Gastroenterology at the University of Manchester. He sat on the HTA EDaPT panel from 2008-2011 and is chair of the Neurogastroenterology and Motility Committee Section of the British Society of Gastroenterology.
Mr Chris Hudson
Chris joined Roche in 1998 as Marketing Manager, Patient Monitoring for UK & Ireland. This business unit included diabetes and point of care products used in both the hospital and the community.
In the last 16 years Chris has held a number of senior leadership positions with Roche both in the UK and globally. This started in 2001 as Business Unit Director of Patient Monitoring and a subsequent move in 2005 to Director of Diabetes Care UK. In 2007 he moved to the global business unit of diabetes care in Germany as Head of Commercial Marketing and became the Head of Blood Glucose Monitoring Marketing in the Roche diabetes care global organisation in 2009.
In 2012, Chris returned to the UK as Director of Roche tissue diagnostics, before becoming Director of the newly formed directorate of Healthcare Development and Strategic Services in 2015. This directorate encompasses the functions of:
- medical affairs
- public affairs
- market access (incorporating health economics)
- strategic accounts
- marketing for services and consulting
- managed laboratory service sales
- the agency businesses in Israel, Malta, Iceland and Cyprus.
Prior to joining Roche, Chris worked in marketing and sales for several international healthcare companies both in the UK and USA.
Outside of Roche, Chris is currently an executive committee member of BIVDA (British In Vitro Diagnostics Association) and the Diagnostic Industry Representative on the MTAC (Medical Technologies Advisory Committee) for NICE.
Dr Cynthia Iglesias
Cynthia Iglesias is senior health economist/ health services researcher at the University of York. She has a first degree in Actuary from the National Autonomous University of Mexico, a MSc in Health Economics and a PhD in Health Services Research, both from the University of York. Cynthia is based at the Department of Health Sciences, and has had honorary appointments with the Hull and York Medical School and the Centre for Health Economics, where she is now an internal affiliate.
Cynthia's main areas of interest are economic evaluation of healthcare technologies; its contribution to healthcare policy decision making and Bayesian Sandy Newbystatistical methods for economic evaluation. In 2008, she started a personal fellowship awarded by the Medical Research Council to look at the potential contribution of Bayesian methods for evidence synthesis to the evaluation of therapeutic medical devices.
Professor Mohammad Ilyas
Mohammad Ilyas is Professor of Pathology at Nottingham University and Honorary Consultant in Pathology at Nottingham University Hospitals NHS Trust. His research interests are focused mainly on the genetic basis of cancer and inflammatory diseases of the gastrointestinal tract. As well as basic cell and molecular biology, he has research interests in the development of molecular diagnostics and has developed protocols for High Resolution Melting analysis (following PCR) to facilitate mutation detection.
Mohammad is on the editorial board of several journals and a founding member of the newly formed Association of Clinical Pathologists Molecular Pathology and Diagnostics group. He has previously worked with NICE on the Colorectal Cancer Guidelines Development Group and the Topic Experts Group used to develop standards from the guidelines. He was a member of the former NICE Topic Selection Consideration panel and he has also provided consultation to NICE on behalf of the Royal College of Pathologists on technology appraisals.
Dr Paul C. Knox
Paul Knox is a Physiology graduate from the University of Glasgow, where he also completed his PhD in Neurobiology. The main focus of his research over the last twelve years has been human vision and eye movement control, using careful measurements to reveal the underlying physiological and cognitive processes involved.
Current work includes the use of concurrent fMRI and eye tracking to study oculomotor initiation (part of an international collaboration with colleagues in China), and the use of new technological approaches to detect eye disease earlier, particularly glaucoma. He also contributes to the training of Nursing and Allied Health Professions undergraduate programmes at the University of Liverpool, as well as Liverpool's NIHR-funded Master of Research in Health Sciences.
Ms Emily Lam
Ms Emily Lam was a registered nurse and obtained a BA (Honours) degree in Psychology through the Open University. After leaving the NHS, Ms Lam set up an education consultancy service that ran for fourteen years.
As a non-executive director of a primary care trust Ms Lam involved users, carers and community organisations in developing quality monitoring and evaluation work. In 2013, while Ms Lam was a lay member on the NICE Guideline Development Group for Chronic Hepatitis B, she initiated a series of chronic hepatitis B health education activities in Manchester in the Chinese community. The work culminated in some local individuals testing positive, and receiving treatment for this asymptomatic but potentially lethal disease.
Over the last sixteen years or so, as a result of serious health problems, Ms Lam has undergone various investigative procedures and this has brought her into close contact with advanced medical technologies. Emily hopes that her understanding and experience as a patient can add value to the discussions and evaluation of potential innovative medical technologies competing for NHS resources.
Dr Avril McCarthy
Avril McCarthy is a Lead Clinical Scientist, within Clinical Engineering at Sheffield Teaching Hospitals NHS Foundation Trust. She leads its successful medical device innovation team, in which device risk management and regulatory compliance are a significant part of her role.
She began her NHS career as a biomedical scientist in haematology before furthering her interest in biomechanics and human factors. Avril was awarded a PhD in 2001 from the Faculty of Engineering at the University of Sheffield for developing and evaluating minimal access orthopaedic ‘virtual environments’ for surgical training. This was followed by several years of EU-funded collaborative research into orthopaedic soft tissue implants involving a number of major medical device, engineering and IT companies.
A founding member of the National Institute for Health Research (NIHR) Devices for Dignity (D4D) HTC since 2008, she has been its MedTech lead, supporting a portfolio of new technologies from incontinence products, to assistive, rehabilitative and renal technologies. She was awarded an Honorary Senior Research Fellowship in 2014 by the School of Health and Related Research (ScHARR) at the University of Sheffield and has been a lead or co-investigator on several NIHR device studies.
Dr Karen McCutcheon
Dr Karen McCutcheon is a registered nurse and a senior lecturer at Queen’s University Belfast, School of Nursing and Midwifery. She is responsible for anaesthetic, perioperative and ophthalmic nurse training and is the academic lead for practice and assessment for undergraduate nursing.
She has published widely in the field of healthcare and education and is the editor of the Journal of Perioperative Practice and is the nurse section editor for BMJ onExamination. She served as a member of the Interventional Procedures Advisory Committee (2006-2016) and has participated in the development of a number of National Patient Safety guidelines in the UK.
Mr Abdullah Pandor
Abdullah Pandor is a Senior Research Fellow in systematic reviewing at the School of Health and Related Research (ScHARR), within the University of Sheffield. He is the Director of ScHARR-TAG Reviews, an academic group which is involved in the production of evidence reports to support health policy decision making by NICE and other national bodies. Abdullah has undertaken research on the clinical effectiveness of healthcare technologies for the National Institute for Health Research (NIHR) Health Technology Assessment Programme for over 15 years and has been involved with the NICE Decision Support Unit.
His research interests include the application and development of systematic review methods. In particular, the review and synthesis of diagnostic and prognostic evaluations, rapid reviews, review techniques for individual patient data and mixed treatment comparisons.
Dr David Partridge
Dr David Partridge is a Consultant Medical Microbiologist and Infection Control Doctor at Sheffield Teaching Hospital NHS Foundation Trust. He is research lead for the Directorate of Laboratory Medicine at the Trust and also sits on the management committee of the Florey Institute for Host-Pathogen Interaction at the University of Sheffield. His clinical interests lie in medical mycology, infections of the immunocompromised host and molecular bacteriology.
He has served as a council member for the British Infection Association since 2009 (as trainee member, membership secretary and finally communications secretary) and also sat on the grants committee of the Healthcare Infection Society from 2015 to 2018.
Dr Jai Patel
Dr Jai Patel is a consultant in vascular and interventional radiology at Leeds Teaching Hospitals NHS Trust (LTHT), appointed in 1999. Together with his colleagues, he provides one of the largest and most comprehensive adult and paediatric vascular interventional radiology services within the UK.
His main areas of clinical interest are in trans-arterial therapies for the treatment of liver tumours, radiological management of portal hypertension and treatment of vascular malformations. He was previously Lead Clinician for vascular radiology at LTHT for 5 years and is currently Deputy Training Programme Director for the West Yorkshire Radiology Training Scheme.
He has previously undertaken national committee work as Education Committee Chair and, more recently, Secretary of the British Society of Interventional Radiology (BSIR). During his time as BSIR Secretary, he provided stakeholder comments on a range of relevant NICE draft Interventional Procedures Guidance and Technology Appraisals.
Professor Carl Roobottom
Mr Andrew Thorpe
Andrew is a Consultant Urologist at the Freeman Hospital, Newcastle upon Tyne. He qualified in Medicine at the University Hospital of Wales, Cardiff in 1981. He trained in Surgery at Cardiff, St Thomas' Hospital London and the Royal London Hospital. He completed an M.Ch. thesis on pelvic floor dysfunction and then went on to train in Urology at the Royal London Hospital, The Royal Berkshire Hospital, Reading and the Freeman Hospital, Newcastle upon Tyne.
Andrew Thorpe's main clinical interests include bladder cancer, bladder dysfunction and urinary incontinence, and new technology for men with bladder outflow obstruction.
His major research areas have been in bladder cancer, urinary incontinence and improving clinical outcomes after radical cystectomy for bladder cancer.
He is a past Honorary Secretary of the British Association of Urological Surgeons (BAUS), a past secretary to the Female Urology Subsection of BAUS, and currently sits on the NIHR Interventional Procedures Panel.
He has acted as an expert witness to the NICE MTAC panel in the past for new procedures to treat bladder outflow obstruction in men.
Professor Allan Wailoo
Allan Wailoo is Professor of Health Economics in the School of Health and Related Research (ScHARR). He is Director of the NICE Decision Support Unit which provides expert research and training support to the Technology Appraisals Programme at NICE. He has interests in all areas of economic evaluation and the analysis of patient level data to inform cost effectiveness models, particularly around health utilities.
Allan has published applied research in a wide range of disease areas. He is a member of the Department of Health's Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) based in Sheffield/York and provides advice to the local NHS as part of the Research Design Service for Yorkshire and the Humber.
He joined the MTAC in January 2012.
Mr John Wilkinson
John Wilkinson took up the post of Director of Devices at the Medicines and Healthcare products Regulatory Agency on 6 February 2012. Prior to this he was Chief Executive of Eucomed, the European medical technology industry association.
His earlier experience included the role of Director General of the Association of British Healthcare Industries and a number of roles in the medical devices industry, both in the UK and the USA, with Becton Dickinson and the BOC Group. These were followed by a period as Chief Executive of an early stage medical imaging company. John holds a first degree in Zoology from the University of Aberdeen and an MBA from the University of Warwick. He was awarded an OBE for services to the medical devices industry in the 2010 new year's honours list.
Mr Alun Williams
Alun Williams is a consultant in transplant surgery and paediatric and adolescent urology at Nottingham University Hospitals. He is co-lead for paediatric transplantation and also for the living donor kidney transplant programme there. Transition and long-term care of congenital problems are further special interests.
He has been a member of the NICE guideline development groups for lower urinary tract dysfunction in neurological disease and for transition from paediatric to adult care, and was also a member of the committee developing quality standards for transition. He was a NICE fellow from 2013 - 16.
Alun’s extracurricular life involves music (clarinet and early music) and horses, although not usually at the same time.
Dr Amber Young
Dr Amber Young has been a consultant paediatric anaesthetist in Bristol since 1999 and currently works at the Bristol Royal Hospital for Children (BRHC) at University Hospitals Bristol NHS Foundation Trust. She trained in Bristol, Great Ormond Street Hospital London and Melbourne Children’s Hospital, Australia. She has interests in paediatric anaesthesia and high dependency care for burns, neurosurgery and major trauma.
She is currently clinical lead for paediatric burn care at the Bristol Children’s Burn Centre, paediatric lead for the SWUK Burn Network and for the Severn and Peninsula Major Trauma networks and Chair of the British Burn Association and Burn Care Clinical Reference Commissioning Group.
Dr Young has written for peer-reviewed journals on burns including toxic shock syndrome, fluid management and costing analysis for children’s burn care. She is clinical lead for collaborative translational research between Bath University and BRHC for rapid diagnosis of infection using smart dressings in paediatric scald injuries which achieved a €4.5 million European Commission grant.
The Healing Foundation Children’s Burns research team in Bristol have also been successful in achieving a five year research programme (July 2012) of which Dr Young is clinical lead.